ArticleCureus2026
Oncocytic (Hürthle Cell) Carcinoma Invading the Innominate Vein: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oncocytic (Hürthle cell) carcinoma is a rare subtype of differentiated thyroid carcinoma associated with increased vascular invasion, distant metastasis, and reduced responsiveness to radioactive iodine (RAI) therapy compared with other thyroid malignancies. Direct invasion of major mediastinal vessels, including the brachiocephalic (innominate) vein, is exceedingly rare and presents significant diagnostic and operative challenges. We report the case of a 71-year-old male who presented with progressive dysphagia and an enlarging multinodular goiter. Initial fine-needle aspiration was benign; however, worsening compressive symptoms prompted left thyroid lobectomy, which demonstrated widely invasive oncocytic carcinoma with extensive angioinvasion (pT3a). Completion thyroidectomy with central neck dissection revealed tumor invasion of the left internal jugular and middle thyroid veins, requiring ligation. Despite adjuvant RAI therapy, serum thyroglobulin (Tg) levels progressively increased. Subsequent positron emission tomography and computed tomography demonstrated a fluorodeoxyglucose (FDG)-avid thrombus and associated venous aneurysm involving the left brachiocephalic vein. The patient underwent successful resection via trapdoor thoracotomy with en bloc excision of the involved venous segment. Pathology confirmed metastatic oncocytic carcinoma with negative margins. This case highlights the importance of vigilant biochemical surveillance, advanced imaging, and aggressive multidisciplinary management in selected patients with oncocytic thyroid carcinoma involving the great vessels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.